Persistent thrombocytosis in ET increases arterial/venous thrombosis risk and, at extreme counts, acquired platelet dysfunction with hemorrhage, making risk stratification and symptom surveillance ...
A high platelet count can lead to blood clots and bleeding, which can be dangerous. Reactive thrombocytosis is often linked to another condition like an infection or inflammation and usually resolves ...
"These patients [with extreme thrombocytosis] had improved overall survival and lower bleeding risk compared to those with normal or low platelet counts at the time of diagnosis." — Marko Lucijanic, ...
Patients with ET experience diagnostic delays, averaging 26.5 months from the first elevated platelet count to diagnosis, indicating potential underestimation of the disease's burden. The study ...
Despite no slam-dunk evidence supporting the use of guided dual antiplatelet therapy (DAPT) strategies, either with platelet function or genotype testing, a new review paper argues that there’s still ...
High neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) are associated with worse progression-free survival and 5-year overall survival in patients with ovarian cancer. The ...